Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 1Hematological Infection 1Gram-Negative Bacterial Infections 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × Colistin × Clear all
NCT03397914 2020-09-16

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

National Cancer Institute, Egypt

Phase 4 Completed
70 enrolled

Neoplasms, Gram-Negative Bacterial Infections

NCT02966457 2017-12-28

DEHAM

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
62 enrolled

Hematological Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡